Peripheral Intravenous Devices
|
|
- Frank Joseph
- 6 years ago
- Views:
Transcription
1 SH CP 140 Peripheral Intravenous Devices Procedures for Peripheral intravenous cannula and Midline intravenous catheters Summary: Keywords (minimum of 5): (To assist policy search engine) Target Audience: Trust procedures for the care and management of Peripheral intravenous cannulae and Midline peripheral intravenous catheters. Includes: Insertion of peripheral cannula Administration of intravenous medication (including flush) via a peripheral device Ongoing care and removal. Intravenous therapy, IV, IV therapy devices, Vascular access device ( VAD) Peripheral intravenous device, PICC, skin tunnelled, implanted port, cannulation, peripheral cannula, midline, insertion, maintenance, removal, flush, diluent, reconstitution, infiltration, extravasation, VIP score, vesicant, phlebitis, thrombosis, thrombophlebitis infusion. All clinical staff Next Review Date: July 2020 Approved and ratified by: Medicines Management Committee Date of meeting: 19/07/17 Date issued: Author: Sponsor: Sharon Guy, Clinical Educator & Mandy Lyons, Clinical Educator Julie Dawes, Director of Nursing and AHP 1
2 Version Control Change Record Date Author Version Page Reason for Change August 2014 April 2017 Jane Byrnell 1 All Replace ANTT terminology with Aseptic Technique Sharon Guy & Mandy Lyons 1 All Title change Reviewed in response to updated Royal College of Nursing Standards for Infusion Therapy and a Safeguard alert regarding NICE guidance on chlorhexidine allergy. Reviewers/contributors Name Position Version Reviewed & Date Theresa Lewis Head of Infection Prevention and Control 1 2 ( May 2017) David Jones Chief Pharmacist 1 Steve Mennear Senior Clinical Pharmacist 1 Zoe Denyer Inwood Day unit Sister 1 Steve Coopey Practice Development Specialist Nurse 1 2 ( April 2017) Claire Hollywell Clinical Educator 1 2
3 Contents Section Title Page 1. Introduction 4 2. Insertion of a peripheral cannula 4 3. Routine flush to maintain patency of peripheral device Administration of intravenous medication Ongoing routine care, including observations and dressing Removal of peripheral cannula 14 3
4 Peripheral Intravenous Devices Procedures for Peripheral intravenous cannula and Midline intravenous catheters 1. Introduction 1.1 These procedures should be read in conjunction with the following Southern Health policies for further information: SH CP 137: Intravenous Therapy and Peripheral cannulation SH CP 13: Aseptic Technique and Clean Technique procedure SH CP 1: Medicines Control, Administration and Prescribing Policy (MCAPP) SH CP 30: Medical Emergencies and Resuscitation Policy 1.2 All Peripheral Cannulation and Intravenous (IV) Therapy administration via a Peripheral Intravenous Device, including flush, requires the use of an aseptic technique, observation of standard precautions and product sterility. 1.3 Aseptic technique (AT): requires individual risk assessment to determine the use of sterile or non-sterile gloves. Sterile gloves are not always required for AT. If there is a likelihood of the Registered Nurse/ Clinician touching the key parts of the system then sterile gloves must be worn. If however you can carry out the procedure without touching the key part with your hands, non-sterile clean gloves may be worn. If the procedure is complex/ technically difficult, or the patient is immuno-compromised, sterile gloves must be worn. 1.4 Gloves: The use of gloves should follow a risk assessment that identifies exposure to blood/ bodily fluids as a risk to the healthcare professional. Well-fitting gloves should be worn to protect hands from contamination from blood, body fluids, secretions and excretions, and to reduce the risk of Cross-contamination to both patient and staff (RCN Therapy, 2016.) 1.4 Aprons: It is recommended that single-use disposable plastic aprons should be worn whilst carrying out ALL infusion procedures, including routine flush, due to the risk of contact with blood/ bodily fluids or contamination of uniform/clothing (RCN Standards for Infusion Therapy, 2016) 2. Insertion of a Peripheral Intravenous Cannula Action Identify clinical need for peripheral cannula insertion. Decontaminate hands as per Southern Health Hand Hygiene Procedure Identify patient by surname, first name and date of birth using open questions checking against NHS/ hospital number. Explain the procedure to the patient; discuss the need for a peripheral cannula, obtaining informed consent for procedure. Establish whether patient has any known or suspected allergies- in particular check for allergy to chlorhexidine. Refer to the Mental Capacity Act 2005 if inserting a peripheral cannula in the Rationale To prevent inappropriate insertion and exposure to associated risks. To reduce the risk of infection. To ensure correct identification of the patient. To ensure patient is informed of procedure. To reduce risk of generalised allergic reaction or anaphylaxis To ensure appropriate insertion is considered. 4
5 patient s best interests. Explain to the patient the importance of keeping the site clean and dry post insertion and discuss risks and signs of infection. If required apply prescribed topical local anaesthetic cream as per manufacturer s instructions for approximately minutes prior to cannulation. Position the patient and make comfortable with appropriate limb positioned below the level of the heart. Collect required equipment: Essential equipment Clinically clean area: tray/ trolley Sterile pack Single use disposable tourniquet Well-fitting disposable gloves Sharps box 2% Chlorhexidine gluconate and 70% alcohol skin preparation wipe, or suitable alternative if allergy or sensitivity to chlorhexidine known or suspected ( ie: povidone iodine in 70% alcohol ) 10 ml Luer lock syringe(s) 1x 10ml 0.9% Sodium Chloride for injection flush Or: 1x prefilled flush ( eg: Posiflush) Cannula:WITH INTEGRAL EXTENSION SET( eg: Tipro One) preferable to ensure closed system Cannula: WITHOUT INTEGRAL EXTENSION SET WILL REQUIRE ADDITION OF A PRIMED EXTENSION SET ( also known as an octopus) 1x Extension set ( also known as an Octopus) primed with 0.9% normal saline for injection ( or compatible alternative) Optional equipment: Topical local anaesthetic Securing device eg: Statlock To educate the patient and reduce risk of infection. To ensure patient comfort. To allow dependent veins to fill with blood. To ensure procedure is performed without disruption to maintain patient safety. Choice of needle safe peripheral cannula must be based on clinical need but the smallest should be chosen to reduce risk of complications associated with larger bores e.g. phlebitis. Maintaining a closed system is recommended to reduce the risk of infection Check all packaging intact before opening Clean identified working area with a Clinell Universal sanitising wipe. In both inpatient and outpatient setting ensure the correct lighting, ventilation, privacy and position of the patient. Support the chosen limb on a pillow To reduce the risk of infection. To ensure comfort and safety of patient and health care professional To ensure patient comfort and ease of access 5
6 Encourage patient to keep limb warm as this increases blood flow, gentle palpation will encourage veins to distend. Assess and select vein; where possible use the non-dominant forearm and avoid areas of flexion. Apply single use disposable tourniquet 10cm above insertion site to aid vein selection Once vein selected release tourniquet and prepare equipment. Select cannula based on vein size Decontaminate hands as per Southern Health Hand Hygiene Procedure Open dressing pack to create aseptic field on cleaned working area. Open equipment onto the aseptic field taking care that any sodium chloride ampoules remain on the cleaned working area, or clean with a single use 2% chlorhexidine gluconate in 70% isopropyl alcohol wipe( or suitable alternative ie: povidone in alcohol, if patient has known or suspected allergy) if placing on the aseptic field. If using a cannula without an integral extension set prime extension set with sodium chloride for injection 0.9% using aseptic technique. If infusion is not to be commenced immediately, prepare 0.9% sodium chloride 10 mls for flush. Clean the patient s skin at the insertion site. Use a grid motion from the proposed puncture site outwards with a single use 2% chlorhexidine gluconate in 70% isopropyl alcohol wipe ( or povidone in alcohol if patient sensitive to chlorhexidine) for 30 seconds and then allow to dry for 30 seconds. Put on gloves and single use disposable apron Reapply single use disposable tourniquet Remove needle guard and inspect device for any faults Anchor the vein with the non-dominant hand by gently pulling on skin a few centimetres below the proposed site of insertion. Grip the cannula as preferred in the dominant hand, ensuring To identify where veins are of adequate size and straight enough to accommodate the cannula. To reduce risk of cannula displacement or mechanical phlebitis To dilate the veins by obstructing venous return. Tourniquet time should be a maximum of 60 seconds to prevent and haemoconcentration and false blood chemistry results. To ensure the patient does not feel discomfort while equipment is prepared. To reduce damage or trauma to vein and reduce risk of phlebitis To reduce the risk of infection. To create a clean working area and reduce infection risk. To remove air from the set prior to connection and reduce the risk of air embolism and infection To maintain patency of cannula To remove skin flora and reduce risk of infection. To prevent contamination of the health care professional from any blood spill To promote venous filling To detect faulty equipment and preserve patient safety To immobilise the vein and provide counter tension, which will facilitate smooth needle entry and a successful pain free cannulation 6
7 bevel is uppermost. Insert the cannula through the skin at an angle of 15 degrees in to the vein. Advance until just in the vein then lower the cannula until it is parallel with the skin ( depending on cannula type a flashback of blood may be seen at this point) Advance the device a further 2-3mm in to the lumen of the vein. As the cannula advances simultaneously pull the needle back using preferred technique ( either 1 or 2 handed) (At this point blood should fill the extension line if a cannula with an integral extension set is used, or blood will be seen along the shaft of the cannula) Release the tourniquet Pull the needle back until the safety device is activated. If using a cannula without an integral extension set apply pressure on the proximal vein, close to the tip of the cannula (a second person may be required for this.) Remove the needle and dispose of it immediately in to a sharps container. If using a cannula without an integral extension set it is now necessary to attach sterile extension set ( octopus ), ensuring it has been previously primed with sterile 0.9% Sodium chloride for injection. Secure cannula with a sterile, transparent, vapour permeable IV dressing. Secure the Y connection with luer lock cap/ bung if required ( depending on cannula type).secure the extension tubing Place date for cannula review sticker to outside of dressing. Flush cannula with 10mL 0.9% sodium chloride for injection (or recommended compatible alternative) using push pause /positive pressure techniques. Never force the solution into the device Following successful insertion ensure patient is comfortable. Dispose of equipment as per the disposal and handling of waste policy. Remove apron and gloves. Decontaminate hands as per Hand Hygiene procedure. Documentation should include: Name, date, time and reason for cannula insertion VIP score (and any removal if cannula is being re sited). To indicate that the needle has entered the vein To stabilise the device To decrease the pressure within the vein To prevent needlestick injury To prevent excessive bleeding during needle-removal. To reduce risk of needle stick injury and prevent blood spillage. To reduce risk of air embolus or mechanical phlebitis To reduce risk of infection and secure cannula in position To prevent pulling/ accidental removal of device and reduce risk of mechanical phlebitis. To ensure timely review. To create turbulent flow that will remove debris from the sides of the lumen and to create positive pressure to maintain patency To prevent damage to the device To ensure patient comfort. To ensure patient and staff safety. To establish an audit trail and monitor management of cannula. 7
8 Details of site preparation and where located. Type and size of vascular access device, Patient response to placement. Complete a Peripheral Cannula Insertion and Management chart (see IV policy) A chart needs to be completed for each separate cannula inserted. Once cannula has been removed this document is filed in the patients notes. In the event of unsuccessful cannulation of the vein, withdraw the peripheral cannula from the puncture site and apply pressure with sterile non-woven swab. Prior to any subsequent attempts at cannulation it is the responsibility of the individual health care professional (HCP) to risk assess the difficulty of further attempts against their own registered competence and experience. If the HCP anticipates the difficulty level to be beyond their scope of practice, then referral to more experienced, competent practitioners should be made. Maximum of two attempts before contacting senior staff. A new cannula is required for each insertion. DAY CASE: A cannula insertion and management chart is not required; details of insertion and removal of the patient s cannula need only be documented fully in the notes. To minimise haematoma formation and /or excessive bruising. To ensure cannulation is always undertaken by competent registered nurses and minimise risks associated with failed attempts at gaining venous access. Cannula inserted for procedure only and in situ for less than six hours and then removed. 3. Routine flush to maintain patency of peripheral intravenous device 3.1 For Peripheral Cannulae and Midline Catheters10mls 0.9% sodium chloride for injection (or recommended compatible alternative) should be used to flush before, between medicines and after medicine administration, or at least once daily to maintain patency 3.2 Syringes for medicine administration and flushing must be Luer lock with a minimum size of 10mL. 3.3 The principles of administration of flush for a Midline peripheral intravenous catheter are the same as that of a Central venous catheter. However, the tip of the Midline catheter rests in the axillary region and therefore does not need X-ray to confirm placement unless difficulties with flushing. 3.4 Do not attempt blood withdrawal or collection from a Peripheral cannula, except at time of insertion. 8
9 Procedure for flushing a peripheral intravenous device (Peripheral cannula and Midline intravenous catheter) Action Identify clinical need for procedure Decontaminate hands as per Hands Hygiene Procedure. Identify patient by surname, first name and date of birth using open questions checking against NHS/ hospital number. Explain the procedure to the patient obtaining informed consent for procedure. Establish whether patient has any known or suspected allergies- in particular check for allergy to chlorhexidine. Refer to the Mental Capacity Act 2005 when appropriate and consider if intervention is in the patients best interests. Inspect the peripheral cannula site or midline catheter insertion site for signs of skin discolouration or infection using a Visual Infusion Phlebitis Score (VIPS) and document accordingly. Ascertain whether the patient has experienced any new symptoms of pain, discomfort or swelling; whether the cannula or midline catheter has been pulled or caught and whether the exterior length of the midline device remains constant. Identify a working area (eg: clean, plastic, re-usable wipe-clean tray) and clean with a Clinell Universal sanitising wipe. In both inpatient and outpatient setting ensure the correct lighting, ventilation, privacy and position of the patient. Collect required equipment: Aseptic field Gloves Apron Sharps box 2% chlorhexidine gluconate in 70% Isopropyl alcohol e.g. Clinell Single Use Device wipes or suitable alternative ( povidone iodine in alcohol if suspected or known allergy. 10 ml Luer lock syringe Needle to draw up flush solution 0.9% sodium chloride for injection ( or compatible alternative) NB: There are pre-prepared 10mL syringes containing 0.9%sodium chloride for injection available (e.g. BD Posiflush) which remove the need to Rationale To prevent inappropriate intervention and exposure to associated risks. To prevent infection. To ensure correct identification of the patient. To ensure patient is informed of procedure. To reduce risk of generalised allergic reaction or anaphylaxis To ensure consent for insertion is obtained, and that the insertion of the device is appropriate for the patient. To assess for risk of infection being present. To assess whether the peripheral cannula or midline catheter may be malpositioned or displaced To reduce the risk of infection. To ensure comfort and safety of patient and health care professional To reduce risk of interruption during procedure. 9
10 use needles to draw up the solution from an ampoule. Decontaminate and dry hands and put on clean gloves and apron Prepare aseptic field with equipment required to carry out flush procedure. Using a suitable cleansing agent, wipe clean ampoules containing flush if required using aseptic technique for at least 30 seconds and place on edge of aseptic field and allow to air dry for at least 30 seconds and draw up flush solution in to syringe. Using a suitable cleansing agent and aseptic technique, thoroughly clean the site and the clamp and port for minimum 30 seconds to and place onto sterile paper towel to allow to air dry for 30 seconds. Swanlocks (bungs) should NOT be applied directly onto the peripheral cannula; primed single or double lumen extensions must be used if the cannula does not have an integral extension set. NB : The HCP should aspirate MIDLINES to check blood return prior to administration of medications and/ or solutions. In the absence of a blood return for midlines an attempt should be made to flush the device; if resistance is met force should not be applied ( RCN, 2016). Flush the peripheral intravenous device using an intermittent push pause and positive pressure technique. Never force the solution into the device For peripheral cannulae it may be necessary to remove the device if patency cannot be established Remove the syringe and discard into sharps container as per Sharps Safety and Management Procedure. Replace the hub if visibly contaminated, or every 7 days for a midline device Remove dressing towel and discard. Ensure the patient is comfortable. Remove gloves aprons. Decontaminate hands. Dispose of all waste correctly following Handling & Disposal of Healthcare Waste Policy. Document in patient s records medications administered, any problems encountered and action taken. To prevent infection. To reduce infection risk To render aseptic. To prevent cross infection. To prevent unwanted movement of cannula in the vein as this can cause mechanical phlebitis. To confirm patency, assess catheter function and prevent complications To create turbulent flow that will remove debris from the sides of the lumen and to create positive pressure to maintain patency To prevent damage to the device To prevent unnecessary sharps injury To reduce risk of infection and promote patency of the venous access device. To prevent infection. To ensure patient and staff safety. To comply with Record Keeping Policy, promote continuity of care and patient safety. 10
11 4. Administration of Intravenous Medicines via a Peripheral Device Key Principles: 4.1 Peripheral cannulae and midline peripheral catheters are not suitable for vesicant (caustic) medications, cytotoxic drugs, hyperosmolar solutions, parenteral nutrition, solutions or medications with a ph of less than 5 or greater than The principles of administration of medication for a Midline peripheral catheter are the same as that of a Central catheter. However, the tip of the Midline catheter rests in the axillary region and therefore does not need X-ray to confirm placement, unless difficulties arise with administration or flushing. 4.3 All IV medicines, including diluents and flushes, must be prescribed by a Registered Medical practitioner or Non-Medical Prescriber responsible for the patient s care, either on an in-patient prescription chart or a community administration authorisation sheet and FP Any adjustments to the patient s treatment plan will require a new prescription to be completed. Verbal messages will not be accepted for change in an Intravenous Drug Treatment Plan Procedure for administration of Intravenous Medicines via a peripheral device Action Place the final syringe or infusion and the empty ampoule (s) /vials (s) into a clean, wipe-clean plastic tray, with the prescription, for taking to the patient for administration. Assemble everything required including any flush solution(s). Identify patient by surname, first name and date of birth using open questions checking against NHS number/ hospital number. Explain the procedure to the patient obtaining informed consent for procedure. Establish whether patient has any known or suspected allergies- in particular check for allergy to chlorhexidine. Refer to the Mental Capacity Act 2005 when appropriate and consider if intervention is in the patients best interests. Decontaminate hands as per Hands Hygiene Procedure and apply gloves & apron. Inspect the cannula site or midline catheter insertion site for signs of skin discolouration or infection using a Visual Infusions Phlebitis Score (VIPS) and document accordingly. Ascertain whether the patient has experienced any new symptoms of pain, discomfort or swelling; whether the Rationale To prevent infection and aid administration. To ensure correct identification of the patient. To ensure patient is informed of procedure. To reduce risk of generalised allergic reaction or anaphylaxis To ensure consent for insertion is obtained, and that the insertion of the device is appropriate for the patient. To prevent infection. To assess for risk of infection being present. To assess whether the cannula or midline catheter may be malpositioned or displaced 11
12 cannula or catheter has been pulled or caught since previous therapy, whether the exterior length of the midline peripheral device remains constant. Having checked that an appropriate access device is in place and patent, it is necessary to flush immediately before and after administration of a medicine, and between doses of different medicines administered consecutively. After administration advise the patient to report promptly any soreness at the injection site or any discomfort. Re-check the administration site for signs of leakage, infection or inflammation and continue to monitor the patient. Discard the empty ampoules/vials from which the injection was prepared and any unused medicine in accordance with local waste disposal policy. Ampoules or vials should never be used to prepare more than one injection unless specifically labelled by the manufacturer for multidose use. Make a detailed record of administration in the patient records. All documents and record keeping to be maintained as per Record Keeping Policies, Standards and Standard Operating Procedures. NB: A signed Trust prescription card must be held for all medicines administered by authorised community team members. This includes medicines obtained on FP10HNC/FP10MDA/FP10SS forms. The registered nurse must ensure all medication administered to patients is regularly reviewed by discussion with the patient/carer and the prescriber. Review should be in response to individual patient needs but at least 3 monthly. Report any adverse reactions to Prescriber, Medicine Management and Medicines and Medicine Health care Regulatory Agency MHRA via a Safeguard Incident Form. To adhere to local policy and reduce risk of adverse reaction and maintain patency of device To reduce risk of harm to patients and staff. To comply with Record Keeping Policy, promote continuity of care and patient safety. 12
13 5. Ongoing routine care including observations and dressing Action A Peripheral Cannula Insertion and Monitoring Chart, including VIP Score, should be used for monitoring all intravenous access devices. For a peripheral cannula it needs to be updated at least once daily, or whenever being accessed for IV therapy. For a Midline peripheral catheter it needs to be updated at least once weekly, or whenever being accessed for IV therapy. A VIP score of 2 requires the removal of the device. The peripheral cannula should be replaced in a new site after 72 hours or earlier if clinically indicated. If the device is re-sited, record the new site and why (Licensed to stay in place for up to 96 hours if site is healthy and therapy due to be completed could consider leaving in situ for up to 96 hours). The transparent, IV dressing should be, intact, dry and adherent. If compromised the dressing will need to be changed using aseptic technique. Peripheral Cannula dressings should be changed if soiled or compromised, otherwise they can remain for the life of the cannula. Midline peripheral catheter dressings should be changed if soiled or compromised; otherwise they should be changed every 7 days. Cleansing of skin, should be undertaken using a Chlorhexidine Gluconate 2% with 70% isopropyl alcohol wipe for a minimum of 30 seconds and allowed to air dry for a minimum of 30 seconds. In the event of patient allergy to chlorhexidine, use povidone iodine (10% in aqueous solution) as an alternative cleanser, if compatible with equipment (see manufacturer s guidelines). Dressing: use a sterile, transparent, vapour permeable dressing. Physiological observation chart to be commenced and maintained for all patients receiving intravenous therapy. Fluid balance must be monitored and documented for all patients receiving any IV therapy. Frequency of observations to be decided upon according to individual patient Rationale To monitor the entry site to alert staff to the early signs of phlebitis. To prevent systemic infection. To reduce the risk of infection and promote patency and keep within manufactures licence. To reduce the risk of contamination thus reducing the risk of infection. To reduce the risk of contamination thus reducing the risk of infection. To reduce the risk of contamination thus reducing the risk of infection. To prevent allergic reaction To reduce the risk of contamination thus reducing the risk of infection. To enable early detection of any change in patients condition or signs of infection, complications, adverse reaction or deterioration. To reduce risk of sepsis. 13
14 assessment and therapy required and recorded in the patients care plan. 6. Peripheral Cannula Removal NB: Midline Peripheral Catheters can only be removed by specifically trained and competent staff in an appropriate setting. The risks associated with removal of a Midline include air embolism, and bleeding. Action The peripheral cannula should be removed if there is no continuing clinical indication. Always access peripheral cannula using aseptic technique. Collect equipment required for Peripheral cannula removal, for example a sterile pack or sterile dressing towel to create an aseptic field, gloves, disposable plastic apron, sterile gauze, hypoallergenic tape and a sharps box. Discuss removal with patient, gain consent and position patient comfortably with arm supported. D e c o n t a m in a t e hands before and after each patient contact as per hand hygiene procedure. Wearing gloves & apron gently remove dressing from site lifting the dressing up towards the cannula, and supporting the peripheral cannula throughout and dispose of used dressing into appropriate waste disposal bag. Gently pull peripheral cannula backwards and remove from the vein, using gauze for gentle pressure to the exit site. Dispose of used cannula immediately into sharps box. Apply dressing of gauze secured with hypoallergenic tape, gently but firmly over the site. Dispose of all equipment as per Handling and Disposal of waste policy Remove gloves and apron & decontaminate hands as per the Hand Hygiene Procedure. Document the removal of the peripheral cannula on the Peripheral Cannula insertion and management form, and VIP score, noting any problems encountered and their management. Rationale To reduce the risk of infection. To reduce the risk of infection. To reduce the risk of infection, and promote efficiency and reduce risk. To ensure patient is prepared and ready for procedure. To reduce the risk of infection. To avoid undue trauma. To prevent trauma and to prevent bleeding & risk of haematoma formation. To prevent cross infection and to prevent contamination by blood. To prevent infection and to prevent further bleeding. To ensure staff and patient safety and to prevent infection. To comply with Record keeping policy, promote continuity of care and patient safety. 14
BASINGSTOKE AND NORTH HAMPSHIRE NHS FOUNDATION TRUST. Clinical Policy for Peripheral Venous Cannula Insertion and Management (Adults)
BASINGSTOKE AND NORTH HAMPSHIRE NHS FOUNDATION TRUST Clinical Policy for Peripheral Venous Cannula Insertion and Management (Adults) Reviewed in accordance with The Health and Social Care Act 2008: Code
More informationCurraheen, Co. Cork. Guidelines on the Management and Care of Central Venous Access Devices
Curraheen, Co. Cork. Guidelines on the Management and Care of Central Venous Access Devices Date re-approved: 27 th Jan 2015. Version No: 2 Revision Due: 2018 Index code: CLIN028 Disclaimer: The information
More informationIf viewing a printed copy of this policy, please note it could be expired. Got to to view current policies.
If viewing a printed copy of this policy, please note it could be expired. Got to www.fairview.org/fhipolicies to view current policies. Department Policy Code: D: PC-5575 Entity: Fairview Pharmacy Services
More informationPATIENT CARE PLAN FOR CARE OF PERIPHERAL MIDLINE. Manufacturers specific recommendations should be noted and adhered to by individual practitioners.
PATIENT CARE PLAN FOR CARE OF PERIPHERAL MIDLINE The care plan is designed to be used in conjunction with CINS Guidelines for vascular devices. Manufacturers specific recommendations should be noted and
More informationGuidelines for the Care and Maintenance of Intravenous Access Devices in Paediatric Patients
Guidelines for the Care and Maintenance of Intravenous Access Devices in Paediatric Patients These guidelines have been adapted for local use from the Collaborative Intravenous Nursing Services regional
More informationHome Health Foundation, Inc. To create more permanent IV access for patients undergoing long term IV therapy.
PROCEDURE ORIGINAL DATE: 06/99 Revised Date: 09/02 Home Health Foundation, Inc. SUBJECT: PURPOSE: MIDLINE CATHETER INSERTION To create more permanent IV access for patients undergoing long term IV therapy.
More informationSuccessful IV Starts Revised February 2014
Successful IV Starts Revised February 2014 Why Intravenous Therapy? Used for access to the body s circulation Indications: Administer fluids, blood, medications, and nutrition Obtain laboratory specimens
More informationHOSPITAL INFECTION CONTROL POLICY. Insertion and maintenance of peripheral intravenous cannulae
HOSPITAL INFECTION CONTROL POLICY Policy no: ICU 03Pol2011v02.0 Insertion and maintenance of peripheral intravenous cannulae TITLE SUMMARY Policy & Procedures for the Insertion and Maintenance of Peripheral
More informationNOTTINGHAM CHILDREN S HOSPITAL Nursing Guideline. P07 Care and Management of Children with a Totally Implantable Venous Access Device (Portacath).
NOTTINGHAM CHILDREN S HOSPITAL Nursing Guideline P07 Care and Management of Children with a Totally Implantable Venous Access Device (Portacath). Introduction A Portacath is a central venous access device
More informationVenepuncture and Cannulation. Louise Smith Clinical Nurse Specialist
Venepuncture and Cannulation Louise Smith Clinical Nurse Specialist Outcomes By the end of this session you will be aware of: Basic anatomy Preparation procedures including patient identification Equipment
More informationATI Skills Modules Checklist for Central Venous Access Devices
For faculty use only Educator s name Score Date ATI Skills Modules Checklist for Central Venous Access Devices Student s name Date Verify order Patient record Assess for procedure need Identify, gather,
More informationIf viewing a printed copy of this policy, please note it could be expired. Got to to view current policies.
If viewing a printed copy of this policy, please note it could be expired. Got to www.fairview.org/fhipolicies to view current policies. Department Policy Code: D: PC-5555 Entity: Fairview Pharmacy Services
More informationEmergency clamp should always be readily available in case of accidental catheter fracture
Note: Please see individual policies for further information. Flushing best practice: Always use a 10 diameter syringe or larger when first accessing and when flushing vascular access device (VAD) Use
More informationCENTRAL VENOUS ACCESS DEVICES. BETHANY COLTON
CENTRAL VENOUS ACCESS DEVICES. BETHANY COLTON Aims and Objectives To know what central venous access devices (CVAD) are. Types of CVADS used in haematology. To understand why we use them To know the complications
More informationStandard Operating Procedure for cannulation
Standard Operating Procedure for cannulation Effective date: 26.07.2017 Review due date: 31.03.2019 Original Author Name: Richard Metcalfe Position: PhD Student Date: 05.12.2012 Reviewer Name: Pippa Heath
More informationClinical Guidelines Intravenous Access Care and Maintenance for Adult Patients in hospital and at home
Policy Number LCH-140 This document has been reviewed in line with the Policy Alignment Process for Liverpool Community Health NHS Trust Services. It is a valid Mersey Care document, however due to organisational
More informationInfusion Skills Competency Checklist To be used at annual skills fair or at any other time for IV Competency
Employee Profile Infusion Skills Checklist Last Name First Name Middle Initial Employee Number Employee Discipline Check one: RN LPN Per state specific LPN Practice Acts Direct Supervisor s Name: Date
More informationCentral venous access devices for children with lysosomal storage disorders
Great Ormond Street Hospital for Children NHS Foundation Trust: Information for Families Central venous access devices for children with lysosomal storage disorders This information explains about central
More informationStandard operating procedures for preparation and administration of intramuscular injections. No Action Rationale
Standard operating procedures for preparation and administration of intramuscular injections Preparation Overview No Action Rationale 1 Collect and check all equipment 2 Check that the packaging of all
More informationEducation for Self Administration of Intravenous Therapy HOME IV THERAPY PICC. Portacath
HOME IV THERAPY PICC Portacath Who To contact Cardio-Respiratory Integrated Specialist Services (CRISS) Office hours 0800 1630 hours Ph: 364 0167 Weekends and after hours, phone Christchurch Hospital operator
More informationCHEMOTHERAPY NETWORK GROUP POLICY FOR ADMINISTRATION OF CYTOTOXIC CHEMOTHERAPY
CHEMOTHERAPY NETWORK GROUP POLICY FOR ADMINISTRATION OF CYTOTOXIC CHEMOTHERAPY Version 4.0 March 2016 Review date March 2018 Introduction It is the purpose of this policy to provide clear guidelines that
More informationSOUTHERN HEALTH & SOCIAL CARE TRUST. Children & Young People s Directorate Procedure/Guidelines/Protocol Checklist & Version Control Sheet
Children & Young People s Directorate Procedure/Guidelines/Protocol Checklist & Version Control Sheet 1 Name of Procedure/Guidelines/ Protocol: PROCEDURE FOR PERIPHERAL ARTERIAL CANNULATION 2 Purpose of
More informationDepartment Policy. Code: D:PC Entity: Fairview Pharmacy Services. Department: Fairview Home Infusion. Manual: Policy and Procedure Manual
Entity: Fairview Pharmacy Services Department: Fairview Home Infusion Manual: Policy and Procedure Manual Category: Home Infusion Subject: Midline (Extended Dwell Peripheral) Catheter Care and Management
More informationPer-Q-Cath* PICC Catheters with Excalibur Introducer* System
Bard Access Systems Per-Q-Cath* PICC and Catheters with Excalibur Introducer* System Instructions For Use Table of Contents Table of Contents Page Contents 1 Product Description, Indications & Contraindications
More informationPROCEDURE FOR THE CARE AND MAINTENANCE OF CENTRAL INTRAVENOUS ACCESS DEVICES
PROCEDURE FOR THE CARE AND MAINTENANCE OF CENTRAL INTRAVENOUS ACCESS DEVICES First Issued Issue Version Purpose of Issue/Description of Change Planned Review Date One To ensure a safe and effective procedure
More informationIV Catheter Placement
Year Group: BVSc3 + Document number: CSL_A06 Equipment for this station: Equipment list: IV catheter model, with giving set and red fluid bag IV catheter Bung or T-port Tape two strips cut to size before
More informationCannulating AV Fistula using Buttonhole Technique
Nephrology Directorate Subject: Objective: Prepared by: Cannulating AV Fistula using Buttonhole Technique To enable the safe insertion and removal of needles into arteriovenous fistulae using the buttonhole
More informationPeripheral Cannulation. Procedural guidelines for use with adult patients in community and community hospital settings.
Peripheral Cannulation. Procedural guidelines for use with adult patients in community and community hospital settings. Description: The document describes how clinicians will prepare for and carry out
More informationPREPARATION OF FISTULA NEEDLES TO COMMENCE HAEMODIALYSIS VIA AVF OR GRAFT AND REMOVAL OF NEEDLES AT END OF DIALYSIS SESSION
Nephrology Directorate Lower Lane Fazakerly L9 7AL PREPARATION OF FISTULA NEEDLES TO COMMENCE HAEMODIALYSIS VIA AVF OR GRAFT AND REMOVAL OF NEEDLES AT END OF DIALYSIS SESSION A) PREPARATION Wash hands
More informationPeripherally Inserted Central Catheter (PICC) Booklet
Aintree University Hospital FT PICC Booklet: a real world example This local booklet is an example used in the NICE medical technology guidance adoption support resource for SecurAcath for securing percutaneous
More informationVascular access device selection & placement. Alisa Seangleulur, MD Anesthesiology Department, Faculty of Medicine, Thammasat University
Vascular access device selection & placement Alisa Seangleulur, MD Anesthesiology Department, Faculty of Medicine, Thammasat University How to make the right choice of vascular access device.. Peripheral
More informationSt George Hospital Renal Department Internal Only
RENAL VASCULAR ACCESS CANNULATION POLICY AND PROCEDURE SUMMARY: A functioning arteriovenous fistula (AVF) or arteriovenous graft (AVG) is paramount in the maintenance of regular and optimal haemodialysis
More informationTitle: EZ-IO. Effective Date: January SOG Number: EMS Rescinds:
S O G Title: EZ-IO Effective Date: January 2010 SOG Number: EMS - 25 Rescinds: Scope: Providers Authorized are AIC s in the following certifications EMT-I and EMT-P who have been trained and cleared by
More informationIV Link Staff. Infection Prevention & Control A Learning Package for IV Link Staff
IV Link Staff Infection Prevention & Control A Learning Package for IV Link Staff Purpose This learning package provides key infection prevention messages and direction for knowledge that you require as
More informationIV Fluids Nursing B23 Objectives Serum Osmolality 275 to 295 Isotonic
1 IV Fluids Nursing B23 2 Objectives 3 Serum Osmolality Serum osmolality solute concentration of a solution Higher osmolality means greater pulling power for water Normal serum osmolality is 275 to 295
More informationIV Fluids. Nursing B23. Objectives. Serum Osmolality
IV Fluids Nursing B23 Objectives Discuss the purpose of IV Discuss nursing interventions in IV therapy Identify complications of IV therapy Differentiate between peripheral line, central line, and PICC
More informationFLEXIC ATH LTD. Peripherally Inserted. Instructions n For Use.
FLEXIC ATH LTD * M/29M Peripherally Inserted Catheter Instructions n For Use This leaflet contains instructions for both stan- dard needle-introducer er and protection con- tained M/29 models, i.e., with
More informationA. Complications With Intravenous Catheters FHI B. Central Line Protocol Management of Site Complications C. Intravenous Catheter Complications
Department Policy Entity: Fairview Pharmacy Services Department: Fairview Home Infusion Manual: Policy and Procedure Manual Category: Home Infusion Subject: Peripheral Venous Access Purpose: Fairview Home
More informationBiovalve. A Guide to Peripheral IV Cannulation CANNULATION
Biovalve A Guide to Peripheral IV Cannulation CANNULATION vygon@vygon.co.uk www.vygon.co.uk Biovalve Peripheral IV Cannulation from Vygon (UK) Ltd The information provided here is intended as guidance
More informationIMPORTANT: PLEASE READ
PART III: CONSUMER INFORMATION ALPROLIX [pronounced all prō liks] Coagulation Factor IX (Recombinant), Fc Fusion Protein This leaflet is part III of a three-part "Product Monograph" published when ALPROLIX
More informationHigh Impact Intervention Peripheral intravenous cannula care bundle
High Impact Intervention Peripheral intravenous cannula care bundle Aim To reduce the incidence of peripheral intravenous cannula infections. Introduction The aim of the care bundle, as set out in this
More informationOverview of CVADs. Type of device commonly used. Dwell time Flushing requirement Associated complications. lumens
Source: Clinical Skills Management of Vascular Access Devices Pre-course handbook. Adapted with permission from NHS Lothian Employee and Education Development Team. Overview of CVADs Type of device Veins
More informationValue Life Lifecath Midli n e uide to Lifecath Midline rse s G u N A
Value Life Lifecath Midl ine A Nurse s Guide to Lifecath Midline www.vygon.co.uk vygon@vygon.co.uk Useful Information Lifecath Midline Lifecath Midline Catheter Code: 1296 Peelable Cannula Introducer
More informationNHS GREATER GLASGOW & CLYDE CONTROL OF INFECTION COMMITTEE STANDARD OPERATING PROCEDURE (SOP) INSERTION & MAINTENANCE OF INDWELLING
Page Page 1 of 6 AIM STATEMENT REQUIREMENTS LOCATION TIMING PROCEDURE To minimise the risk of secondary infection as a result of urinary catheterisation. A urinary catheter bypasses the body s normal defence
More informationIMPORTANT: PLEASE READ
PART III: CONSUMER INFORMATION ALPROLIX [pronounced all prō liks] Coagulation Factor IX (Recombinant), Fc Fusion Protein This leaflet is part III of a three-part "Product Monograph" published when ALPROLIX
More informationHome Care Services HomeMed MedEQUIP Michigan Visiting Care Michigan Visiting Nurses Wheelchair Seating Service PROCEDURE
UNIVERSITY OF MICHIGAN HOSPITALS AND HEALTH CENTERS UMHHC-HCS: 253.054 First Approved Date: 3/2010 Home Care Services HomeMed MedEQUIP Michigan Visiting Care Michigan Visiting Nurses Wheelchair Seating
More informationThe Power of Purple* Polyurethane PICC. Patient Guide. Access Systems
The Power of Purple* Polyurethane PICC Patient Guide Access Systems Preamble Your doctor is giving you a PowerPICC* catheter so that you can easily get the intravenous (IV) medicines you need. This catheter
More informationALPROLIX Coagulation Factor IX (Recombinant), Fc Fusion Protein INSTRUCTIONS FOR USE Do not Do not YOUR KIT CONTAINS:
ALPROLIX Coagulation Factor IX (Recombinant), Fc Fusion Protein INSTRUCTIONS FOR USE Read the Instructions for Use before you start using ALPROLIX and each time you get a refill. There may be new information.
More informationDate Authorised 28 September 2015 Dissemination Target Audience All Trust Staff Dissemination and Implementation Plan Action Owner Due by
Peripheral Venous Cannula Insertion and Management (Adults) Policy HH(1)/IC/636/15 Previous document(s) being replaced Location Policy No Policy Name HHFT HH(1)/IC/636/13 Peripheral Venous Cannula Insertion
More informationEducation for self administration of intravenous therapy HOME IV THERAPY. 30 minute - Baxter Pump Tobramycin
HOME IV THERAPY Tobramycin Tobramycin Check the order on the drug chart This can change when the results from your blood test come through. Your doctor will change the order, if required. A copy of the
More informationCentral Venous Catheter Insertion: Assisting
Approved by: Central Venous Catheter Insertion: Assisting Gail Cameron Senior Director, Operations, Maternal, Neonatal & Child Health Programs Dr. Santiago Ensenat Medical Director, Neonatology Neonatal
More informationGroshong Catheters with Introcan Safety Peripheral IV Catheter Introducer
Bard Access Systems Groshong Catheters with Introcan Safety Peripheral IV Catheter Introducer Instructions For Use Table of Contents Table of Contents Page Contents 1 Product Description 2 Product Description,
More information2. Indications Infusion of hyperosmolar medication, e.g. TPN. Administration of vasoactive/irritant drugs.
Policy and Procedure for Insertion and care of Peripherally Inserted Central Catheters by Neonatal Staff (see Ch 8 TPN) 1. Introduction The peripherally inserted central catheter (PICC) is an intravenous
More informationThe University of Toledo Medical Center and its Medical Staff
Name of Policy: Policy Number: Department: 3364-109-GEN-705 Infection Control Medical Staff Hospital Administration Approving Officer: Responsible Agent: Scope: Chair, Infection Control Committee Chief
More informationBLOOD CULTURE POLICY FOR PAEDIATRICS
BLOOD CULTURE POLICY FOR PAEDIATRICS 1. INTRODUCTION Blood culture to detect bacteraemia is an important investigation with major implications for the diagnosis of patients with infection and the selection
More informationCentral Venous Catheter Care and Maintenance (includes catheter troubleshooting guide)
Central Venous Catheter Care and Maintenance (includes catheter troubleshooting guide) A Guide for Patients in the Home Phone Number: Nurse/Contact: Central Venous Catheters This manual is a guide for
More informationBPG 03: Continuous Renal Replacement Therapy (CRRT)
BPG 03: Continuous Renal Replacement Therapy (CRRT) Statement of Best Practice Patient s requiring Continuous Renal Replacement Therapy (CRRT) will receive appropriate therapy to meet their individual
More informationJo Kuehn, RN, MSN, CPHQ Jenell Westhoven, RN, BSN
Jo Kuehn, RN, MSN, CPHQ Jenell Westhoven, RN, BSN Disclosure Information Intravenous Therapy and Parenteral Nutrition Administration: Nursing In- Focus Jo Kuehn, RN, MSN, CPHQ and Jenell Westhoven, RN,
More informationDirect Intravenous (IV) Medication Administration Procedure
Approved by: Chief Medical Officer; and Chief Operating Officer Direct Intravenous (IV) Medication Administration Procedure Corporate Policy & Procedures Manual Number: VII-B-310 Date Approved January
More informationVascular access in practice: best practice update
Vascular access in practice: best practice update Nicola York Clinical Nurse Manager Vascular Access Oxford University Hospitals NHS Foundation Trust June 2016 Objectives Patient assessment Best practice
More informationCentral Line Care and Management
Central Line Care and Management What is a Central Line/ CVAD? (central venous access device) A vascular infusion device that terminates at or close to the heart or in one of the great vessels (aorta,
More informationMANITOBA RENAL PROGRAM
SUBJECT Venipuncture of Arteriovenous Fistula/Graft MANITOBA RENAL PROGRAM SECTION CODE 30.30.01 30.30 Vascular Access AUTHORIZATION Professional Advisory Committee, Manitoba Renal Program Nursing Practice
More informationMANITOBA RENAL PROGRAM
SUBJECT Venipuncture of Arteriovenous Fistula/Graft MANITOBA RENAL PROGRAM SECTION CODE 30.20.01 30.20 Vascular Access AUTHORIZATION Professional Advisory Committee, Manitoba Renal Program Nursing Practice
More informationPatient/Carer instructions for the administration of Subcutaneous Cytarabine
Patient/Carer instructions for the administration of Subcutaneous Cytarabine This document covers the following information: What cytarabine is What subcutaneous means What happens if you decide to inject
More informationSARASOTA MEMORIAL HOSPITAL. NURSING PROCEDURE INTRAOSSEOUS NEEDLE: INSERTION, CARE, AND REMOVAL (inv08) 12/18 12/18 1 of 7 RESPONSIBILITY:
SARASOTA MEMORIAL HOSPITAL TITLE: ISSUED FOR: NURSING PROCEDURE INTRAOSSEOUS NEEDLE: INSERTION, CARE, AND REMOVAL (inv08) Nursing DATE: REVIEWED: PAGES: 12/18 12/18 1 of 7 RESPONSIBILITY: PS1094 Insertion-
More informationGUIDELINES FOR PERFORMING AN INTRAPERITONEAL UROKINASE LOCK
GUIDELINES FOR PERFORMING AN INTRAPERITONEAL UROKINASE LOCK Contact Name and Job Title (author) Directorate & Speciality Jr Sr Vanessa Keill Diabetes, Infection, Renal and Cardiovascular Directorate (Renal
More informationARROW ENDURANCE. Extended Dwell Peripheral Catheter System. Rx only.
ARROW ENDURANCE Extended Dwell Peripheral Catheter System Rx only. Product Description: The ARROW Endurance catheter system is a sterile, single use peripheral intravascular device designed to permit access
More informationTitle: Greater Manchester and Cheshire Cancer Network Policy for the Care of long term Central Venous Catheters
Title: Greater Manchester and Cheshire Cancer Network Policy for the Care of long term Central Venous Catheters Purpose: For staff to be aware of policies and guidelines for the care of long term Central
More informationNetwork Policy for the Care and Management of Central Venous Access Devices (CVAD) in Adults.
Network Policy for the Care and Management of Central Venous Access Devices (CVAD) in Adults. Quality and safety for every patient every time Document Control Prepared By Sharon Harper Wendy Anderson Issue
More informationSCIG INFUSIONS A PRACTICAL GUIDE FOR PATIENTS
PRIMARY IMMUNODEFICIENCIES SCIG INFUSIONS: A PRACTICAL GUIDE FOR PATIENTS SCIG INFUSIONS A PRACTICAL GUIDE FOR PATIENTS 1 PRIMARY IMMUNODEFICIENCIES ABBREVIATIONS IG IVIG PID SCIG Immunoglobulin Intravenous
More informationMANAGEMENT OF INTRAVASCULAR (IV) LINES AND THERAPY. All GCC Countries
TITLE/DESCRIPTION: MANAGEMENT OF INTRAVASCULAR (IV) LINES AND THERAPY INDEX NUMBER: EFFECTIVE DATE: APPLIES TO: ISSUING AUTHORITY: 01/01/2009 01/01/2013 All GCC Countries GULF COOPERATION COUNCIL CENTRE
More informationGroshong* PICC and Catheters
Bard Access Systems Groshong* PICC and Catheters Instructions For Use Table of Contents Table of Contents Page Contents 1 Product Description 2 Product Description, Indications & Contraindications 3 Contraindications,
More informationPolicy for the safe handling and administration of cytotoxic drugs for Children, Teenagers and Young Adults with Cancer
Policy for the safe handling and administration of cytotoxic drugs for Children, Teenagers and Young Adults with Cancer Introduction Cytotoxic drugs are used to treat cancer and a number of other disorders.
More informationKINGSTON GENERAL HOSPITAL NURSING POLICY AND PROCEDURE
KINGSTON GENERAL HOSPITAL NURSING POLICY AND PROCEDURE SUBJECT Sample (Adult): Advanced Competency (AC) for Nurses (Registered Nurses and Registered Practical Nurses) PAGE 1 of 5 ORIGINAL ISSUE 1985 January
More informationBLOOD COLLECTION GUIDELINES
I. Patient Identification Lee Memorial Health System Lee County, FL CLINICAL LABORATORY BLOOD COLLECTION GUIDELINES A. Inpatient / Outpatient with armband 1. When possible, ask patient to state their name
More informationFundamentals of Flushing and Locking
Fundamentals of Flushing and Locking Vascular Access Devices Fundamentals of Flushing and Locking Purpose, Product, and Process 2016 BD. BD and the BD Logo are trademarks of Becton, Dickinson and Company.
More information1.0 Purpose The purpose of this guideline is to ensure the safe administration of intramuscular injections to Cheshire Ireland service users.
Status: Guideline: offers direction and guidance on good practice, need not necessarily be strictly adhered to. Page 1 of 5 Title: Guidelines for Administration of an Intramuscular Injection Written by:
More informationSTEP-BY-STEP GUIDE TO SELF-INFUSION. Subcutaneous Administration of GAMMAGARD LIQUID
STEP-BY-STEP GUIDE TO SELF-INFUSION Subcutaneous Administration of GAMMAGARD LIQUID This handy guide will help you manage your subcutaneous administration of GAMMAGARD LIQUID. If you have questions on
More informationChapter 8 ADMINISTRATION OF BLOOD COMPONENTS
Chapter 8 ADMINISTRATION OF BLOOD COMPONENTS PRACTICE POINTS Give the right blood product to the right patient at the right time. Failure to correctly check the patient or the pack can be fatal. At the
More informationEVOGAM. Information for patients Evogam 2014 NZ Patient Brochure Update v11
EVOGAM Information for patients 11881 Evogam 2014 NZ Patient Brochure Update v11 Information for patients and caregivers about EVOGAM This booklet is designed to help you follow the training you will have
More informationCentral Venous Catheter (CVC) Care for an Infant, Child or Young Person
Central Venous Catheter (CVC) Care for an Infant, Child or Young Person Contents 1. Introduction 2. Principles 3. Definitions 4. CVC types 5. CVC Insertion Bundle 6. CVC Care Bundle 7. Nursing management
More informationPLEASE FOLLOW STEP BY STEP GUIDE ENCLOSED. FLUSH WEEKLY WITH SALINE AND CLEAN SITE WEEKLY WITH CHLORAPREPP : chlorhexidine 2% in 70% alcohol.
South Wales Intravenous Access Advisory Group Guidelines for the care and maintenance of a Tunnelled Cuffed Catheter (TCC) e.g. Hickman, Broviac PLEASE FOLLOW STEP BY STEP GUIDE ENCLOSED. FLUSH WEEKLY
More informationSTANDARDIZED PROCEDURE REPROGRAMMING AND REFILLING INTRATHECAL BACLOFEN PUMPS and ACCESSING THE CATHETER ACCESS PORT (Adult,Peds)
I. Definition The purpose of this procedure is to allow the Advanced Health Practitioner (AHP) to reprogram and refill intrathecal Baclofen pumps, as well as access the catheter access port for those AHPs
More informationVenesection Nursing Guidelines
Venesection Nursing Guidelines Rationale Patients requiring venesection on the Day Treatment Unit (DTU) fall into 3 main categories; patients diagnosed with: Polycythemia Rubra Vera Haemachromatosis Transfusion
More informationSAFE HANDLING OF VACCINES
STANDARD OPERATING PROCEDURE SAFE HANDLING OF VACCINES Issue History Issue Version One Purpose of Issue/Description of Change Planned Review Date To ensure vaccines are stored in accordance with manufacturers
More informationChildren s Acute Transport Service
Children s Acute Transport Service Vascular Access Document Control Information Author Ramnarayan Author Position Consultant, CATS Document Owner Polke Document Owner Position CATS Co-ordinator Document
More informationPfizer, BeneFIX R2 Recombinant Factor IX
Pfizer, BeneFIX R2 Recombinant Factor IX BeneFIX, Recombinant Factor IX, is indicated for the prevention and control of bleeding episodes in people with hemophilia B (Christmas Disease). BeneFIX is also
More informationAdult Vascular Access Policy
Adult Vascular Access Policy Lead Manager: Margaret Connolly Responsible Director: David Stewart Approved by: GGC Clinical Governance Group Date approved: Date: Updated November 2014 Date for Review: Date:
More informationMANITOBA RENAL PROGRAM
MANITOBA RENAL PROGRAM SUBJECT Use of Closed Needleless Access Device with Hemodialysis Central Venous Catheters (CVC) SECTION CODE 30.20.04 30.20 Vascular Access AUTHORIZATION Professional Advisory Committee,
More informationPatient Information Publications Warren Grant Magnuson Clinical Center National Institutes of Health
Warren Grant Magnuson Clinical Center National Institutes of Health What is a subcutaneous injection? A subcutaneous injection is given in the fatty layer of tissue just under the skin. A subcutaneous
More informationDocument No. BMB/IFU/40 Rev No. & Date 00 & 15/11/2017 Issue No & Date 01 & 15/11/2017
Central Venous Catheter Device Description Multi-lumen catheters incorporate separate, non-communicating vascular access lumens within a single catheter body. Minipunctur Access Sets And Trays: Used for
More informationWhat is a Leaderflex catheter?
Leaderf lex How to care for your catheter patient gu ide www.vygon.co.uk vygon@vygon.co.uk This booklet will give you information about the care your catheter and things to look out for. For any other
More informationEffective Date: Approved by: Laboratory Executive Director, Ed Hughes (electronic signature)
1 Policy #: 406 (PLH-406-02) Effective Date: NA Reviewed Date: 2/1/2008 Subject: VENIPUNCTURE PROCEDURE Approved by: Laboratory Executive Director, Ed Hughes (electronic signature) Approved by: Laboratory
More informationCentral Venous Access Devices. Stephanie Cunningham Amy Waters
Central Venous Access Devices Stephanie Cunningham Amy Waters 5 Must Know Facts About CVAD s 1) What are CVAD s? 2) What are CVAD s used for? 3) How are these devices put in? 4) What are the complications
More informationARROW EZ-IO Intraosseous Vascular Access System Procedure Template
ARROW EZ-IO Intraosseous Vascular Access System Procedure Template PURPOSE To provide procedural guidance for establishment of intraosseous vascular access using the ARROW EZ-IO Intraosseous Vascular Access
More informationThe Impact of Healthcare Associated Infection (HCAI)
Instructions for use Save this presentation Feel free to add or delete slides as necessary, change information to suit local needs and as new guidance or evidence is published Disclaimer: Whilst the working
More informationIV therapy. By: Susan Mberenga, RN, MSN. Copyright 2016, 2013, 2010, 2006, 2002 by Saunders, an imprint of Elsevier Inc.
IV therapy By: Susan Mberenga, RN, MSN 1 IV Therapy Types of solutions Isotonic Hypotonic Hypertonic Caution: Too rapid or excessive infusion of any IV fluid has the potential to cause serious problems
More informationPeripheral Venous Cannula (PVC) Management Guidelines
Peripheral Venous Cannula (PVC) Management Guidelines This procedural document supersedes: PAT/T 45 v.2 Peripheral Venous Cannulation (PVC) Insertion and Management Guidelines Did you print this document
More informationUpdated version of the South Wales Intravenous Access Advisory Group
Updated version of the South Wales Intravenous Access Advisory Group Guidelines for the care and maintenance of a Tunnelled Cuffed Catheter (TCC) e.g. Hickman, Broviac PLEASE FOLLOW STEP BY STEP GUIDE
More informationEL DORADO COUNTY EMS AGENCY FIELD PROCEDURES
EL DORADO COUNTY EMS AGENCY FIELD PROCEDURES Effective: July 1, 2017 Reviewed: November 9, 2016 Revised: November 9, 2016 EMS Agency Medical Director INTRAOSSEOUS INFUSION PURPOSE: To establish immediate
More information